机译:随机,多中心,双盲,第三阶段研究,以评估哮喘和过敏性鼻炎术患者蒙特洛斯特和左甲基嗪的联合鼻炎和安全性的疗效
Subdivision of Allergy Department of Internal Medicine Chungbuk National University College of;
Division of Allergy Department of Internal Medicine The Catholic University of Korea;
Department of Allergy and Clinical Immunology Ajou University School of Medicine;
Division of Allergy and Respiratory Medicine Department of Internal Medicine Hanyang University;
Department of Internal Medicine Yonsei University Wonju College of Medicine;
Division of Allergy and Clinical Immunology Department of Internal Medicine Ewha Womans;
Pulmonary-Allergy Division Department of Internal Medicine Konkuk University College of Medicine;
Department of Internal Medicine College of Medicine Dong-A University;
Department of Internal Medicine Kosin University College of Medicine;
Department of Internal Medicine Yonsei University College of Medicine;
Department of Internal Medicine Seoul National University College of Medicine;
Department of Internal Medicine Yeungnam University College of Medicine;
Division of Respirology and Allergy Department of Internal Medicine Chung-Ang University College;
Division of Allergy Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Allergy and Clinical Immunology Department of Internal Medicine Seoul National;
Division of Pulmonology Allergy and Critical Care Medicine Department of Internal Medicine Pusan;
Division of Pulmonology Allergy and Critical Care Medicine Department of Internal Medicine Korea;
Division of Allergy and Clinical Immunology Department of Internal Medicine Asan Medical Center;
Department of Internal Medicine Dankook University College of Medicine;
Department of Internal Medicine Kyungpook National University School of Medicine;
Hanmi Pharmaceutical Co;
Division of Allergy and Respiratory Medicine Department of Internal Medicine Soonchunhyang;
allergic rhinitis; asthma; clinical trial; fixed-dose combination; levocetirizine; montelukast;
机译:随机,多中心,双盲,第三阶段研究,以评估哮喘和过敏性鼻炎术患者蒙特洛斯特和左甲基嗪的联合鼻炎和安全性的疗效
机译:随机,多中心,双盲,第三阶段研究,以评估哮喘和过敏性鼻炎患者Montelukast和Levetizine的组合治疗的疗效和安全性
机译:随机,多中心,双盲,第三阶段研究,以评估哮喘和过敏性鼻炎患者Montelukast和Levetizine的组合治疗的疗效和安全性
机译:局部和系统干扰素治疗免疫性鼻炎和支气管哮喘的免疫科植物治疗患者
机译:鼻充血和农村居民对哮喘和过敏性鼻炎成人的肺功能和哮喘控制的影响。
机译:骨化剂在季节性变应性鼻炎中的功效和安全性:第2期和第3期随机双盲安慰剂和活性对照研究的结果
机译:与季节性过敏性鼻炎患者的孟鲁斯特和左甲基嗪FDC片剂的疗效和安全性评价:随机,双盲,多期,第II期试验